We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Myhealthchecked Plc | LSE:MHC | London | Ordinary Share | GB00BN7K5L93 | ORD 1.5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 10.00 | 0.00 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.50 | 10.50 | 10.00 | 10.00 | 10.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 10.98M | -159k | -0.0031 | -32.26 | 5.2M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 10.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/6/2024 | 10:54 | UK RNS | MyHealthChecked PLC Result of AGM |
| 04/6/2024 | 16:41 | ALNC |  EARNINGS AND TRADING: Hummingbird loss narrows as revenue climbs |
| 04/6/2024 | 07:00 | UK RNS | MyHealthChecked PLC Final Results & Notice of AGM |
| 22/5/2024 | 07:00 | UK RNS | MyHealthChecked PLC Notice of Results |
| 10/5/2024 | 17:15 | UK RNS | MyHealthChecked PLC Holding(s) in Company |
| 11/1/2024 | 11:52 | ALNC | IN BRIEF: MyHealthChecked expects 2023 earnings breakeven |
| 11/1/2024 | 07:00 | UKREG | MyHealthChecked PLC Trading Update |
| 27/12/2023 | 12:58 | UKREG | MyHealthChecked PLC Holding(s) in Company |
| 25/9/2023 | 13:13 | UKREG | MyHealthChecked PLC Grant of Options |
| 19/9/2023 | 11:50 | ALNC | TRADING UPDATES: Maintel outlook promising; Good Energy revenue up |
Myhealthchecked (MHC) Share Charts1 Year Myhealthchecked Chart |
|
1 Month Myhealthchecked Chart |
Intraday Myhealthchecked Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 25/7/2024 | 13:52 | MyHealthChecked PLC to 100p | 9,955 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Myhealthchecked Daily Update Myhealthchecked Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker MHC. The last closing price for Myhealthchecked was 10p.Myhealthchecked currently has 52,005,932 shares in issue. The market capitalisation of Myhealthchecked is £5,200,593. Myhealthchecked has a price to earnings ratio (PE ratio) of -32.26. This morning MHC shares opened at 10p |
Posted at 24/7/2024 16:35 by tia01 I guess that Covid has been running wild over the month of June and July so I guess that February until May it’s reasonable to expect a slowdown as alerted to in recent results. The interesting thing is last year we seen a pick up in late July/August so it’s clearly a summer wave. My guess is winter will bring its own issues as last years pattern showed.I’m hopeful that Penny will issue news soon regarding plans with Boots etc regarding new products and arrangements. It will interesting to note that MHC did state they planned to increase the shelves in an extra 250! Stores or 200! Stores. All fully funded. I believe a decent second half could result in more cash to continue expansion with new range. I’m also optimistic Penny will deliver on recent statements in the investor meeting as regards news with Boots etc. We must remain optimistic and I’m fully aware many will say MHC has been a terrible investment given the share performance but I genuinely believe MHC can deliver news shortly that has the potential to really ramp up revenue. |
Posted at 18/7/2024 12:52 by tia01 Personally I think Covid Revenue is and has been hugely valuable otherwise it would have been a disaster with dilution.The key is what the plans are with Boots and MHC 100%. Penny clearly has briefed us on a deal in recent months at the investor meeting. However until this is clarified and relayed to the market I guess nothing will happen. I also guess given they are in talks with Boots it’s clear Directors can not buy any to support the share price. Either way I believe many investors heavily down and totally confused by the lengthy time it’s taken for any news which is why price keeps drifting lower. Do I personally feel the price is way undervalued!. 100% News needed urgently as investors are losing patience and moving on. That could be a mistake as News definitely imminent. |
Posted at 30/6/2024 09:52 by tia01 I took this morning to read the Chairman’s Statement and it’s clear a slowdown is expected in Covid tests in the first half of 2024.Is it all bad news! I personally see a slowdown that will see sales of Covid for first six months of 2024 to come in at around 3m based on 1 test being sold in each of the 1900 stores nationwide and also online sales during the period. You may think ouch but as stated in Chairman’s statement a decline is expected. The good thing is it’s evident the other tests provided by MHC will make up for lost revenue from the Covid tests as sales increase. I don’t expect a huge amount of revenue from new tests but it’s reasonable to expect between half a million and three quarters in the first half. So I would anticipate a similar overall figure to the first half in 2023 with combined sales and wellness tests. The key will be any update that may lead to an anticipated huge uptick in wellness test sales in Boots. We are expanding to another 200plus stores with wellness tests however this will come at a cost to MHC for the initial costs of shelving and stock etc. It will however add to the long term growth of revenue. It’s also self funded. I do expect strong cost control to reserve cash and also believe any collaboration with Boots pharmacy first and phlebotomy testing privately within Boots instore MOT services available could provide a catalyst needed. I don’t think a buy back will be announced although it would be a great idea. I believe the company will prioritise using cash for growing the business instead. I believe MHC should use Tik Tok content creators who advertise for free and at a cost of MHC sending a free sample to demonstrate. Of course MHC would need to sell the products on TIk Tok shop in order for content creators to access them and offer free promotions. TIk Tok viewers are probably between 16 to 40 but many of the tests are geared towards these ages and then we must remember that all these 18-40s have older family members they may buy a test for. Remember if you give a free test to 20 Tik Tok members who each have 20,000 plus followers for example that a potential sale to 400,000 off just 20 free samples! Times this by 50 free samples etc you see how quick it would be to get the brand out there for literally nothing. Then you have the benefits of being on TIK TOK shop. This would be great if they have a deal with Boots and use Tik Tok viewers to make people aware of the products and services etc. It would also help encourage direct sales to MHC and enhance the user rate of the digital data. MHC must be smart a use the 8m of cash wisely to gain traction to wellness tests which are the future of the business whilst Covid revenue is this available. Covid revenue is the key to growth without dilution and valuable for MHC. A recent surge in Covid cases will reflect in 2nd half results in my opinion as Boots will buy tests in advance based on the figures and projections to ensure they are stocked for winter 2024 and summer 2024. The market will only react to news flow from MHC which is expected imminently. Penny has a great opportunity to demonstrate the future of wellness testing combined with the importance of digital data which Poc Doc has demonstrated is the future |
Posted at 19/6/2024 22:15 by tia01 SpacedustI do share your view. Penny is smart enough to realise no real money in LFT £7.99p tests. Phlebotomy tests is collaboration with Boots will bring about change. Possibly more tests added to pharmacy first to help relieve pressure off GPs etc. COVID revenue still steady and seasonal. Digital Data to help large companies and insurance companies etc. Look at Poc Doc and you’ll understand the way forward is digital data which Penny invested in heavily. Peoples habits will change however it will take time and investment which is why COVID revenue is vital. If deals are done and RNS prior to half year update we could see a sharp rise as people see potential huge revenue growth. Then we have products going into 200 more stores so it’s clear the strategy is Boots and Pharmacy first and instore testing. Dont under estimate how smart Penny is. She was smart enough to make money from Covid and probably the smartest thing was to continue with the Covid tests which have driven cash and enabled self funded growth. Is it painful to watch the share price doing title!. Yes 100%. I’d love a small buyback to encourage new money to follow and Directors to buy also but we need to see. A 10% buyback would cost the company £500,000 however we would probably see 50% jump in share price which would be the best investment for MHC. Sometimes buying your own stock is better than an acquisition in the long run if you believe in your business strategy. I truly believe in Penny and do believe her hands are tied ATM because of Boots a regulation on news. Client confidentiality etc. Fingers crossed for all LTHs but stay the course and add more if you have cash at these levels in my opinion |
Posted at 04/6/2024 17:30 by tia01 Listening was interesting and it would appear they are working on a few things which Penny said they intend to share with the market over coming months!. Maybe one reason they can’t buy shares if they have price sensitive information.Seems like B2B with insurance is area of potential growth. Still happy with cash position penny says and self sufficient. I bet if share rose suddenly we could see and acquisition and capital raise. Not quite what to make when asked about ABDX. LFT tests never seemed to be her main focus. Nothing said from Chairman. Honestly I can’t believe how low share price is on cash alone compared to competitors and their positions financially and market caps out there. Maybe this may change and they may get some credit for being self sufficient and not needing to dilute over the years. Most investors bailed already after huge losses and I don’t believe any investors making any capital return on investment so far. Far to say you must believe share price can go use from these levels but who knows |
Posted at 01/6/2024 10:39 by tia01 ControlYou summed it up well. It’s a shame the markets keep selling it off. I see ABDX bought a company using shares etc. MHC have cash and need to do something with it to help expand more rapidly whilst many companies struggling. Now could be a time for an acquisition given how cheap many companies are. I’m sure the board have evaluated this and well aware of the opportunities out there. For me I I just hope the board don’t just rely on Boots because IMO Boots doing deals with ABDX shows they have no loyalty to MHC products. I do believe an incoming Labour Party may wish to get waiting list and cost down regards GPs etc and if MHC products were to be made available to Boots Pharmacy for prescription to use in conjunction with Boots trained pharmacy staff then MHC and Boots could have a huge beneficial and meaningful relationship. That depends on the Government as shown in recent changes in some products be prescribed in Boots. I do worry that Penny and the board are not focusing on investors Importance and value. I say this because since lockdown many of us are 90% down so a rise of 10% has no impact. Also lack of news offers little incentive to average down. I hope they truly offer something to change this and can demonstrate organic growth in revenue out side of Covid products giving optimism to the markets. We mustn’t take away how well Penny and the board have done growing the cash position whilst being self sufficient and not needing to return to the market for capital raises. This in itself is a major success however the market will be focusing on the growth potential in revenue and ability to convert it to profit. |
Posted at 25/5/2024 08:15 by tia01 I recall when it was announced Donald had a 3% stake it rocketed to near 15p! From lows. Maybe he should have cashed in.Can Penny offer any good news and support to the share price!. Strange but crazy to think MHC has remained in a healthy position financially through a difficult period of high inflation and interest rates that had destroyed many other businesses. Can MHC demonstrate growth and a path to expand revenue through new products to convince the markets it truly is a growth story or will they judge it on Covid revenue alone. That said Covid revenue up to 31st December was solid however new product sales growth is the true figure MHC may be judged on. Either way it’s been a painful time for holders of MHC over the last few years. |
Posted at 15/5/2024 17:11 by tia01 BillyThe radio silence is reflected in the share price and surely the board can see this. All I can say is given our financial position I feel the markets have it wrong with competitors valuations as to MHC. However market work off updates and PR etc so MHC should realise this is having a devastating effect of share holders |
Posted at 18/3/2024 07:55 by tia01 After comparing MHC and ABDX you can’t help notice quite a few points.ABDX market cap over 10m MHC over 6.5m ABDX has around 1.9m MHC has around 8m plus ABDX has a high cash burn and needed fund raises. MHC is prudent and cash in the bank growing. ABDX concentrated on revenue growth. MHC concentrated on cash flow and growth. ABDX main product is salistick MHC has over 20 Products So is ABDX Market Cap of 10m justified! Or is MHCs 6.5m way undervalued! Hopefully end of year results will show growth for MHC and we push up to levels of our competitors to reflect the facts. |
Posted at 21/2/2024 19:37 by tia01 Black horseWithout being disrespectful but Money obviously moving to MHC which is why we are 50% up from December roughly. Given we are on MHC site I’m happy to discuss money inflowing to MHC. All be it I wish a bit bit quicker lol. The fact is it’s ticking up without any one noticing it so hopefully a good RNS will come and get MHC noticed. I do see resistance at 16-17p if we get there as this was the figure around the time we fell early 2023 when the poor figures landed. I do however feel whilst we have seen a slowdown in covid sales that it’s possible new products are gaining traction. I do think a explanation as to why some of the good likes like intolerance tests are out of stock for so long online but can only assume that potential buyers will still go to stores nearby or use MHCs site directly. I feel the next set of results will be a much better set than lasts years. More cash in the bank and I have a sneaky feeling we are probably going to drop news on a few new products in my opinion. Also need a plan to move more expensive ones otherwise you have to judge if production costs are worth it in the sales figures given they have shelf life expiring dates. Also is MHC a takeover target with cash situation and no debts. I just wonder why Directors not buying and wonder if they are excluded because they are privileged to News coming. All my own personal beliefs but hopefully something soon to take it up to the next level and back to 25p plus as Spacedust said |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
